ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ABUS Arbutus Biopharma Corporation

2,73
0,01 (0,37%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Arbutus Biopharma Corporation ABUS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,01 0,37% 2,73 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,73 2,70 2,78 2,73 2,72
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/04/202408:30GLOBEArbutus to Report First Quarter 2024 Financial Results and..
04/04/202409:30GLOBEArbutus Biopharma Announces Claim Construction Ruling in its..
08/03/202409:30GLOBEArbutus to Participate in Two Upcoming Investor Conferences
29/02/202409:30GLOBEArbutus Reports Fourth Quarter and Year End 2023 Financial..
15/02/202409:30GLOBEArbutus to Report Fourth Quarter and Year End 2023 Financial..
08/01/202409:30GLOBEArbutus Announces 2024 Corporate Objectives and Provides..
08/11/202309:30GLOBEArbutus to Present at Jefferies London Healthcare Conference
07/11/202309:30GLOBEArbutus Reports Third Quarter 2023 Financial Results and..
07/11/202309:15GLOBEArbutus Announces CEO, William Collier, to Retire December..
24/10/202308:30GLOBEArbutus to Report Third Quarter 2023 Financial Results and..
18/10/202308:30GLOBEArbutus to Present at H.C. Wainwright 4th Annual Hepatitis B..
11/10/202309:05GLOBEArbutus Announces Multiple Abstracts Accepted for..
11/09/202317:15GLOBEArbutus Announces Pipeline Updates and Dosing of the First..
07/09/202308:30GLOBEArbutus to Participate in Two Upcoming Investor Conferences
03/08/202308:30GLOBEArbutus Reports Second Quarter 2023 Financial Results..
20/07/202308:30GLOBEArbutus to Report Second Quarter 2023 Financial Results and..
12/07/202308:30GLOBEArbutus Appoints Melissa V. Rewolinski, PhD to its Board of..
10/07/202317:01GLOBEArbutus Appoints Two New Executives
21/06/202308:30GLOBEArbutus Doses First Patient in Additional Treatment Arm of..
21/06/202303:01GLOBEArbutus Presents Preliminary AB-729 and Pegylated Interferon..
07/06/202303:01GLOBEArbutus to Present AB-729 and AB-836 Data at EASL Congress..
31/05/202308:30GLOBEArbutus to Present at Jefferies Healthcare Conference
09/05/202308:30GLOBEArbutus to Present at JMP Securities Life Sciences..
04/05/202308:30GLOBEArbutus Reports First Quarter 2023 Financial Results and..

Seu Histórico Recente

Delayed Upgrade Clock